『ADSN』のカバーアート

ADSN

ADSN

著者: James Borow and Daniel Druger
無料で聴く

ADSN (The Ads Network) is a weekly show for people building and investing in ads, media, and monetization products. Every Tuesday, join James Borow and Daniel Druger as they bring over 30 years of experience to discuss the headlines and the why and how behind them. They also welcome industry leaders to go deep on topics in a fun and approachable format. Join the ADSN crew every Tuesday 🗓️James Borow and Daniel Druger 政治・政府
エピソード
  • 30 minutes: How AI Can Make the Economy Better & Why AI Pessimists Are Wrong ft. Eric Seufert
    2026/08/31

    Eric Seufert, the mind behind Mobile Dev Memo, released a 4-part series called The Prosperous Society. In it, Eric lays out a deeply optimistic case for AI's impact on the economy: as AI-enabled tools reduce the friction around both production and distribution, the binding constraint flips from production to distribution, and the digital advertising economy becomes accessible to businesses that were previously locked out entirely. He argues this leads to a collapse of the Pareto Principle, where products no longer need massive audiences to be viable, and consumers get matched with the exact products that fit their tastes — a state he calls "commerce at the limit."

    The conversation takes a sharp turn into why Eric is deeply skeptical of agentic commerce. His argument is simple: shopping is self-expression, and delegating purchases to an agent strips consumers of agency. He also points out the incentive structures don't work — Amazon and Walmart will never let third-party agents intermediate their platforms, and the data backs it up. Walmart's Sparky drives 40% more items per transaction, Amazon's Rufus hit $12 billion in incremental sales, and chat ads across platforms like ChatGPT are already past a billion in revenue. Eric also flags what he calls the coming "balkanization" of AI use cases, where platforms like Meta pull up the drawbridge around enterprise verticals like media buying with dedicated AI business agents.


    Thank you to our sponsors:

    • AdQuick – Making OOH advertising as easy to plan, buy, and measure as digital. adquick.com
    • Thrad.ai — Building the advertising infrastructure for AI. thrad.ai
    • beehiiv — The all-in-one platform for newsletters, websites, and every tool you need to grow and earn. beehiiv.com
    • The Farm — Fraction commercial legal with an in-house approach to outside counsel. thefarmllp.com


    STAY CONNECTED

    James on Twitter & LinkedIn – /jamesborow

    Daniel on LinkedIn, Instagram, TikTok – /danieldruger

    Subscribe & leave a ⭐⭐⭐⭐⭐ review on Spotify & Apple Podcasts.

    続きを読む 一部表示
    30 分
  • ADSN RUNDOWN | Humanoid Robots, Live Commerce, Anthropic's $2T Moment
    2026/08/27

    This week's ADSN Rundown covers a packed slate, starting with True Classic running QVC-style live video directly on its homepage and whether that model or agentic commerce has a better shot at reshaping e-com. Daniel and James dig into Nikita Bier's take on shipping fast at X, where press releases were written 20 minutes before launch, and why overthinking go-to-market is a trap. They break down reporting that Chinese institutions are building AI models of American voters to test political messaging, the implications for open-source models, and what it means for platforms like TikTok. Olivia Moore's data on agent token consumption makes the case that API-first product strategy is no longer a debate. The guys also cover Instagram's new in-comments site preloading, the 1840s origins of the word "slop" and its AI parallel, Josh Wolf one-shotting a full motion graphic video with Claude Code, and a humanoid robot running 100 meters faster than Usain Bolt at China's robot games.


    On the business side, Rohan Dar points out that Anthropic's rumored $2 trillion IPO would be four times larger than every San Francisco IPO in history combined. A new "Tech Trades" segment tracks major talent moves: Jeremy Voss and Alex Osborne joining Airbnb from Snap/Tinder, Eric Toda becoming CMO at Air, and Luke Kallis landing at Agbo, the gaming company co-founded by the creator of Fortnite and the Russo Brothers. Primary posts this week highlight Jeff Morris Jr. cold-texting Lance Armstrong for a bike ride and Ed O'Neill's masterclass in playing the long game when negotiating for Modern Family.


    Thank you to our sponsors:

    • AdQuick – Making OOH advertising as easy to plan, buy, and measure as digital. adquick.com
    • Thrad.ai — Building the advertising infrastructure for AI. thrad.ai
    • beehiiv — The all-in-one platform for newsletters, websites, and every tool you need to grow and earn. beehiiv.com
    • The Farm — Fraction commercial legal with an in-house approach to outside counsel. thefarmllp.com


    STAY CONNECTEDJames on Twitter & LinkedIn – /jamesborowDaniel on LinkedIn, Instagram, TikTok – /danieldruger
    Subscribe & leave a ⭐⭐⭐⭐⭐ review on Spotify & Apple Podcasts.

    続きを読む 一部表示
    26 分
  • 30 Minutes: Peptides, GLP-1s and the DIY Health Revolution ft. Dr. Neil Paulvin
    2026/08/21

    "The health paradigm has totally changed. It's never going back to where you're just going to go see your doctor in the physical office and get treated. That's never going to happen again."


    Dr. Neil Paulvin, a board-certified physician with over 20 years of experience in integrative medicine joins 30 Minutes to cut through the BS when it comes to peptides and DIY health. Dr. Paulvin has been prescribing peptides since 2017 and breaks down the six major categories, from anti-inflammatory and muscle building to the vanity stacks covering weight loss, hair, and skin. He explains why BPC-157, the most hyped peptide on social media, still lacks proper human studies because no one can patent it or justify the $5-10 million needed for clinical trials, and why marketing names like "Wolverine Stack" and "Glow" are made-up terms from unregulated sellers, not real medical protocols.

    The conversation covers where the industry is headed: big pharma is expected to control 75-80% of the peptide market within 3-5 years by patenting slightly modified versions of existing peptides. Dr. Paulvin also walks through retatrutide (GLP-3), which he calls the "home run of all home runs" but warns comes with significantly stronger side effects. He makes the case that peptides do work at the right dosing for the right patient, but stresses that Manhattan bodegas selling them at the front counter is a sign the industry has "jumped the shark," and that none of this replaces the fundamentals of sleep, exercise, diet, and stress management.


    Thank you to our sponsors:

    • AdQuick – Making OOH advertising as easy to plan, buy, and measure as digital. adquick.com
    • Thrad.ai — Building the advertising infrastructure for AI. thrad.ai
    • beehiiv — The all-in-one platform for newsletters, websites, and every tool you need to grow and earn. beehiiv.com
    • The Farm — Fraction commercial legal with an in-house approach to outside counsel. thefarmllp.com


    STAY CONNECTEDJames on Twitter & LinkedIn – /jamesborowDaniel on LinkedIn, Instagram, TikTok – /danieldruger

    Subscribe & leave a ⭐⭐⭐⭐⭐ review on Spotify & Apple Podcasts.

    続きを読む 一部表示
    28 分
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません